Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng–Tongji cohort study

Serum alpha‐fetoprotein (AFP) is the most commonly used tumor biomarker for screening and diagnosis of primary hepatocellular carcinoma (HCC). However, the predictive effect for HCC risk is still unsatisfactory. The aim of this prospective study was to estimate whether the individual genetic correct...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Wang, Ke, Bai, Yansen, Chen, Shi, Huang, Jiao, Yuan, Jing, Chen, Weihong, Yao, Ping, Miao, Xiaoping, Wang, Youjie, Liang, Yuan, Zhang, Xiaomin, He, Meian, Yang, Handong, Guo, Huan, Wei, Sheng
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Cancer Prevention
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6010894/
https://ncbi.nlm.nih.gov/pubmed/29696820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1481
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky